Corbus Pharmaceuticals Holdings CRBP
NASDAQ CRBP
$10.38 +0.54 (+5.49%)
At close: Aug 21, 2026 · 4:00 PM EDT

Corbus Pharmaceuticals Holdings (CRBP) Change in Cash (2013 - 2025)

Corbus Pharmaceuticals Holdings (CRBP) posted quarterly Change in Cash of $6.9 million for Q3 2025, up 262.77% year-over-year from $1.9 million in Q3 2024, and up 506.56% quarter-over-quarter from $1.1 million in Q2 2025.

Corbus Pharmaceuticals Holdings (CRBP) Change in Cash (2013 - 2025) Analysis & Trends

Corbus Pharmaceuticals Holdings' Change in Cash history runs 13 years deep, the most recent figure standing at $6.9 million for Q3 2025.

  • In Q3 2025, Change in Cash rose 262.77% year-over-year to $6.9 million; the TTM figure through Sep 2025 stood at $7.6 million (down 7.51% YoY), while the FY2024 annual figure was $3.5 million, up 205.95% from the prior year.
  • Change in Cash for Q3 2025 stood at $6.9 million, up from $1.1 million in the prior quarter.
  • The five-year high for Change in Cash was $32.0 million in Q1 2022, with the low at -$31.3 million in Q2 2022.
  • The 5-year median for Change in Cash is $1.0 million (2023), against an average of -$3.1 million.
  • The sharpest annual moves came in 2022 and 2024: Change in Cash sank 1383.47% in 2022, then soared 835.59% in 2024.
  • Corbus Pharmaceuticals Holdings' Change in Cash stood at -$12.1 million in 2021, then jumped by 137.64% to $4.6 million in 2022, then plunged by 45.71% to $2.5 million in 2023, then plunged by 189.9% to -$2.2 million in 2024, then surged by 411.87% to $6.9 million in 2025.
  • Business Quant data shows CRBP's Change in Cash at $6.9 million in Q3 2025, $1.1 million in Q2 2025, and $1.7 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -185.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 427.25 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -2.94 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -2.83 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -37.42 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 225.59 Mn
10 Corbus Pharmaceuticals Holdings 127.63 Mn -35.64 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 6.94 Mn
Jun 30, 2025 1.14 Mn
Mar 31, 2025 1.70 Mn
Dec 31, 2024 -2.23 Mn
Sep 30, 2024 -4.26 Mn
Jun 30, 2024 9.58 Mn
Mar 31, 2024 379,000.00
Dec 31, 2023 2.48 Mn
Sep 30, 2023 2.90 Mn
Jun 30, 2023 1.02 Mn
Mar 31, 2023 -9.68 Mn
Dec 31, 2022 4.56 Mn
Sep 30, 2022 -13.33 Mn
Jun 30, 2022 -31.26 Mn
Mar 31, 2022 32.02 Mn
Dec 31, 2021 -12.11 Mn
Sep 30, 2021 1.04 Mn
Jun 30, 2021 -30.88 Mn
Mar 31, 2021 -18.82 Mn
Dec 31, 2020 3.56 Mn